Effects of different treatment methods on clinical efficacy and fertility outcomes of patients with adenomyosis

Table 4 Comparison of hormone levels

Groups	Time	Luteinizing hormone (IU/L)	Follicle-stimulating hormone (IU/L)	Estradiol (pmol/L)
Group A (n = 35)	Before treatment	18.91 ± 2.13	15.02 ± 2.21	288.17 ± 32.85
Group A (n = 35)	After treatment	16.50 ± 1.85*	13.44 ± 1.55*	236.22 ± 22.38*
Group B (n = 35)	Before treatment	18.23 ± 2.18	14.92 ± 2.16	289.52 ± 32.14
Group B (n = 35)	After treatment	14.96 ± 1.69*#	10.16 ± 1.27*#	206.93 ± 21.66*#
Group C (n = 35)	Before treatment	18.46 ± 2.17	15.09 ± 2.32	286.75 ± 33.55
Group C (n = 35)	After treatment	14.28 ± 1.61*#	11.31 ± 1.31*#	209.40 ± 22.68*#
Group D (n = 35)	Before treatment	18.70 ± 2.45	15.41 ± 2.13	285.07 ± 30.21
Group D (n = 35)	After treatment	11.40 ± 1.19*#$&	9.33 ± 1.07*#$&	183.37 ± 17.81*#$&

Note: * P < 0.05 vs. before treatment; # P < 0.05 vs. group A; $ P < 0.05 vs. group B; & P < 0.05 vs. group C

ISSN: 1757-2215